Study objectives: To investigate whether psychological factors predict outcome after emergency treatment for obstructive pulmonary disease. Setting: Emergency department at a university hospital. Patients: Forty-three patients presenting with exacerbation of asthma or COPD. Intervention: The patients received emergency treatment and were followed up for 4 weeks. Measurement: Spirometry, blood sampling, pulse oximetry, breathing rate, pulse rate, and dyspnea score was measured before and during emergency treatment. The psychological status was assessed using the hospital anxiety and depression (HAD) scale questionnaire at the end of the follow-up period. Results: Anxiety and/or depression was found in 17 patients (40%). Of these patients, nine patients (53%) were admitted to hospital or had a relapse within 1 month, compared with five patients (19%) in the group without anxiety and/or depression (p < 0.05). Among patients who relapsed within 1 month (n ‫؍‬ 14), the HAD total score was 12.4 ؎ 5.9 compared with 8.6 ؎ 5.1 (mean ؎ SD) among the patients without a relapse (p < 0.05). After making adjustments for age, gender, atopic status, treatment, and pack-years, the significant association between treatment failure and anxiety and/or depression still remained. 
A cute exacerbations of obstructive pulmonary disease are a very common reason for medical emergency treatment. There is a subgroup of patients who repeatedly visit the emergency department. 1 Decompensated COPD has been shown to be one of the most common causes of return visits to an emergency department. 2 Relapses in acute asthma are also common. In one American study, 3 approximately 25% of patients treated for asthma relapsed within 3 weeks of being seen at the emergency department. Baseline disease severity did not account for the relapses. In another study, 4 asthmatic patients with many emergency visits had evidence of greater nonadherence to asthma treatment. Stehr et al 5 found that psychosocial factors, such as being widowed or divorced, were closely correlated to relapses among male patients with COPD. The aim of this study was to investigate whether psychological factors assessed by the hospital anxiety and depression (HAD) questionnaire are correlated to the risk of relapse in consecutive patients with acute exacerbations of obstructive pulmonary disease.
Materials and Methods
The study comprised adult patients (Ͼ 18 years old) with acute exacerbations of obstructive pulmonary disease, both asthma and COPD, presenting during the day at our emergency department. They were all assessed as being in need of emergency treatment. They were excluded if immediate hospital admission was deemed necessary or if they were unable to perform lung function tests. All participation was voluntary, and the study was approved by the Ethics Committee at the Medical Faculty at Uppsala University.
The respiratory rate and oxygen saturation (Nellcor N-20P; Nellcor Incorporated; Hayward, CA) were measured on arrival. Patients were then asked to rate their dyspnea according to the Borg modified scale. 6 -10 Before treatment, all patients were examined and spirometry (Vitalograph Alfa; Vitalograph Ltd; Buckingham, UK) was performed. The best value from three recordings was chosen. The predicted FEV 1 value was calculated for each patient. 11 Spirometry was repeated after 2 h. Venous blood samples were obtained. Patients were interviewed about their smoking history, and the number of pack-years was calculated. The clinical diagnosis of asthma and COPD was based on previous history, symptoms, and earlier investigations recorded in the case notes. The HAD questionnaire was completed by the patients at the follow-up visit after 4 weeks. All relapses were recorded during the 4 weeks after the emergency visit. A relapse was defined as any hospital contact at which antiobstructive treatment was administered. Patient information was checked against hospital records.
All patients were administered 5 to 15 mg of nebulized salbutamol (in one to three doses) via Ventstream with a Porta Neb compressor (Medic Aid Ltd.; West Sussex, UK). If necessary, oxygen was administered. The patients were treated after randomization with 60 mg of oral prednisolone followed by 30 mg/d of prednisolone for 1 week, with 4 mg of budesonide suspension (2 mg/mL), followed by 1,600 g/d of budesonide (via dry-powder inhaler) for 1 week or no steroid treatment in the acute phase but the inhalation of 400 g qid of budesonide immediately after discharge. For the following 3 weeks, all patients were treated with 1,600 g/d of budesonide. 12 
Atopic Status
Phadiatope (Pharmacia & Upjohn Diagnostics, Uppsala, Sweden) was used to classify patients as atopic or nonatopic.
HAD Questionnaire
The self-reported HAD questionnaire 13 has been used extensively to screen psychiatric morbidity 14 -16 and has high validity when it is used as a screening instrument for psychiatric morbidity in outpatients. 17 It consists of 14 questions: 7 questions are related to anxiety and 7 questions are related to depression. Each item is rated on a 4-point scale, giving maximum subscale scores of 21 for anxiety and depression, respectively. Zigmond and Snaith 13 recommended that scores of Ն 8 on a subscale should be taken as an indication of possible pathology.
Statistical Methods
The statistical analyses were performed with StatView 5.0 (SAS Institute; Cary, NC). Comparisons between patients with and without anxiety or depression were performed using the MannWhitney U test for continuous variables, while the 2 test was used for comparisons of proportions. The Kaplan-Meier survival analysis was used to study the difference in time to relapse between patients with and without anxiety/depression. Multivariate analysis was performed by multiple logistic regression. A p value Յ 0.05 was regarded as statistically significant.
Results
Fifty patients were included in the investigation. We obtained full records from 43 patients who were evaluated in this study. The mean age was 65.3 years (range, 22 to 87 years). Nineteen patients were men (mean age, 65.8 years), and 24 were women (mean age, 64.8 years). Sixteen patients (37%) had an anxiety score of Ն 8 (probable anxiety), 5 patients (12%) had a depression score of Ն 8 (probable depression), 4 patients (9%) had both an anxiety and a depression score of Ն 8, and 17 patients (40%) had either probable anxiety and/or depression. The mean HAD total score was 9.8. The characteristics of patients with and without anxiety and/or depression are shown in Table 1 . No significant differences between the groups were seen with regard to age, gender, smoking history, or severity of the attack. Of the 43 patients, 28 patients had a clinical diagnosis of asthma and 15 patients had COPD.
The emergency treatment was unsuccessful in 14 patients: 3 patients could not be discharged after the emergency treatment, 6 patients relapsed within 1 week, and a further 5 patients relapsed within 1 month. The characteristics of the patients with and without treatment failure are shown in Table 2 . The patients who relapsed within 1 month had a significantly lower FEV 1 before treatment than the patients who did not relapse.
In the group of patients with probable anxiety and/or depression, nine patients (53%) relapsed within 1 month compared with five patients (19%) in the group without anxiety/depression (p Ͻ 0.05). The psychological characteristics of patients with and without a relapse within 1 month are shown in Table  3 . Patients with treatment failure had a significantly higher HAD total score, and the number of patients with probable anxiety/depression was higher. The In a multiple logistic regression analysis, the association of different variables with treatment failure was studied with adjustments for age, gender, packyears, emergency treatment, and atopic status. The results are shown in Table 4 . A significant correlation between psychological factors and the risk of treatment failure was also found when replacing probable anxiety and/or depression with the HAD total score (odds ratio, 1.18; 95% confidence interval, 1.01 to 1.39). Replacing pack-years with the clinical diagnosis of asthma or COPD did not significantly change our results. The adjusted odds ratio for the relationship between probable anxiety and/or depression and treatment failure was 7.1 (95% confidence interval, 1.1 to 53.4) in this model.
Discussion
The main finding of this study is that patients who had a relapse after emergency treatment of obstructive pulmonary disease are more likely to report signs of anxiety and/or depression. We have not found similar studies for comparison, but our results are in accordance with those of some other studies. In the study by Stehr et al 5 involving male patients with COPD, psychosocial factors such as experiencing the loss of a first-order relative and being more pessimistic about the prognosis, were more common among the group of relapses. Yohannes et al 18 found that anxiety was a major predicting factor for frequency of hospital admission for acute exacerbations of COPD in elderly patients (aged 60 to 89 years). In studies of brittle asthma, near-fatal asthma, and asthma deaths, a high prevalence of psychiatric disorders and psychosocial problems has been reported. 19 -27 This could mean that there is an association between asthma severity and psychological disability. In the study by Dales et al, 1 however, no association could be found between psychological health and the risk of relapses. The prevalence of anxiety and depression in our patient group was higher than what has been found in the general population in Sweden. Lisspers et al 28 evaluated the HAD scale in a Swedish population sample and found a prevalence of probable anxiety of 12% (in our study, 37%), of probable depression of 9% (in our study, 12%) and a total HAD score of 8.5 (in our study, 9.8). The age group investigated was 30 to 59 years, which makes direct comparisons with our study difficult. Centanni et al 29 studied 80 asthmatic outpatients and found significantly higher levels of depression and anxiety than in the control groups consisting of patients with chronic liver disease and healthy subjects.
It has been shown that emotional stimuli induce asthmatic attacks and reductions in FEV 1 , 30 -32 but it does not appear that asthmatic patients as a whole have a specific personality profile. 14, 33, 34 In COPD, several studies have 18, [35] [36] [37] [38] shown a high prevalence of emotional disturbance, anxiety, and depression, but in one study of unselected, elderly patients with COPD, depressive symptoms were equally common among patients and control subjects. 39 One reason for the high prevalence of psychiatric morbidity in our study might be that the patients in our study were selected because they had visited an emergency department.
The HAD questionnaire was administered at the visit at the end of the study period. The reason for this was that we wanted to evaluate the patients in as steady a state as possible, in order to avoid the acute psychological effects of the emergency visit. A drawback with this approach is that the relapse in itself may have negatively affected the patient's psychological well-being. While we cannot exclude this possibility, it should be pointed out that only one of the of the patients had a relapse within the last 10 days preceding the psychological evaluation, and this patient did not have probable anxiety or depression.
Our study group comprised both asthma and COPD patients, as it is often difficult, especially in the acute phase, to distinguish asthma from COPD. Looking at the groups separately, asthmatic patients with a relapse had a higher HAD score than the asthmatics with successful emergency treatment. The same trend was also found in the COPD group, although the difference here was not statistically significant. With the limited number of patients included in our study, it is therefore difficult to conclude whether the relationship between psychological factors and the outcome of emergency treatment is different in asthma and COPD.
Our study indicates that anxiety and depression are related to the outcome of emergency treatment in patients with obstructive pulmonary disease. Further studies should be conducted evaluating the effect of treatment of anxiety and depression in patients with recurrent exacerbations of asthma and COPD.
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